Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke.

Cite this paper

@article{Leys2016ProportionOS, title={Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke.}, author={Didier Leys and Yannick Hommet and Cl{\'e}mence Jacquet and Sol{\`e}ne L Y Moulin and Igor Sibon and J-L Mas and Thierry Moulin and Maurice E Giroud and Sharmila Sagnier and Charlotte Cordonnier and Elisabeth Medeiros de Bustos and G Turc and Thomas Ronzi{\`e}re and Yannick B{\'e}jot and O Detante and Thavarak Ouk and Anne-Marie Mendyk and Pascal Favrole and M Zuber and Aude Triquenot-Bagan and Ozlem Ozkul-Wermester and Francisco Macian Montoro and Chantal Lamy and Anthony Faivre and Laurent Lebouvier and Camille Potey and Mathilde Poli and Hilde H{\'e}non and Pauline Renou and Nelly Dequatre-Ponchelle and Marie Bodenant and Sabrina Debruxelles and Costanza Rossi and R{\'e}gis Bordet and Denis Vivien}, journal={Neurology}, year={2016}, volume={87 23}, pages={2416-2426} }